Quidel loses bid to stop Beckman from directly selling BNP assay; shares down 19% [Seeking Alpha]
Inspire Medical Systems, Inc. (INSP)
Last inspire medical systems, inc. earnings: 2/25 04:15 pm
Check Earnings Report
Company Research
Source: Seeking Alpha
Thinly traded Quidel ( QDEL ) is down on modestly higher volume, albeit on turnover of only 299K shares, in response to the news that Beckman has prevailed in a lawsuit related to the sale of test called B-type natriuretic peptide (BNP). The company owns exclusive rights to sell the test, called Triage BNP, on Beckman Coulter analyzers but Beckman wants to sell the test directly to its customers. The California court intends to enter an order allowing Beckman to do just that. Quidel says the litigation is broader that this one issue and it expects to ultimately prevail. The trial remains scheduled for August 30, 2019. The situation arose from Abbott's takeout of Alere more than a year ago. The BNP rights were in-licensed by BioSite Diagnostics in late 1996. BioSite was subsequently acquired by Alere (then d/b/a Inverness Medical Innovations). In order to satisfy antitrust concerns with the Abbott tie-up, Alere sold its Triage MeterPro and Triage BNP lines to Quidel.
Show less
Read more
Impact Snapshot
Event Time:
INSP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
INSP alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
INSP alerts
High impacting Inspire Medical Systems, Inc. news events
Weekly update
A roundup of the hottest topics
INSP
News
- Inspire Medical Systems, Inc. (NYSE: INSP) is now covered by analysts at Royal Bank of Canada. They set an "outperform" rating and a $285.00 price target on the stock.MarketBeat
- Inspire (INSP) Surges 9.9%: Is This an Indication of Further Gains? [Yahoo! Finance]Yahoo! Finance
- Recent 7.0% pullback isn't enough to hurt long-term Inspire Medical Systems (NYSE:INSP) shareholders, they're still up 353% over 5 years [Yahoo! Finance]Yahoo! Finance
- Want Better Returns? Don't Ignore These 2 Medical Stocks Set to Beat Earnings [Yahoo! Finance]Yahoo! Finance
- Inspire Medical Systems: A Potential Example Of Market Mispricing [Seeking Alpha]Seeking Alpha
INSP
Earnings
- 2/6/24 - Beat
INSP
Sec Filings
- 4/18/24 - Form 4
- 4/17/24 - Form 144
- 4/16/24 - Form 4
- INSP's page on the SEC website